Clone ID | DMC463 |
---|---|
Target | |
Synonyms | TF; Coagulation factor III; F3 |
Host Species | Rabbit |
Description | Biotinylated Anti-CD142 antibody(DMC463); IgG1 Chimeric mAb |
Delivery | 2-3 weeks |
Uniprot ID | P13726 |
IgG type | Rabbit/Human Fc chimeric IgG1 |
Clonality | Monoclonal |
Reactivity | Human |
Applications | Flow Cyt |
Recommended Dilutions | Flow Cyt 1:100 |
Purification | Purified from cell culture supernatant by affinity chromatography |
Formulation & Reconstitution | Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution. |
Storage & Shipping | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature. |
Background | This gene encodes coagulation factor III which is a cell surface glycoprotein. This factor enables cells to initiate the blood coagulation cascades; and it functions as the high-affinity receptor for the coagulation factor VII. The resulting complex provides a catalytic event that is responsible for initiation of the coagulation protease cascades by specific limited proteolysis. Unlike the other cofactors of these protease cascades; which circulate as nonfunctional precursors; this factor is a potent initiator that is fully functional when expressed on cell surfaces; for example; on monocytes. There are 3 distinct domains of this factor: extracellular; transmembrane; and cytoplasmic. Platelets and monocytes have been shown to express this coagulation factor under procoagulatory and proinflammatory stimuli; and a major role in HIV-associated coagulopathy has been described. Platelet-dependent monocyte expression of coagulation factor III has been described to be associated with Coronavirus Disease 2019 (COVID-19) severity and mortality. This protein is the only one in the coagulation pathway for which a congenital deficiency has not been described. Alternate splicing results in multiple transcript variants.[provided by RefSeq; Aug 2020] |
Usage | Research use only;All DIMA recombinant antibodies are genuinely generated by DIMA Biotech. They are all under patent application. Any protein sequencing or reverse engineering attempt is prohibited. We are actively scrutinizing all patent application to ensure no IP infringement. |
Conjugate | Biotinylated |
Biotinylated Anti-CD142 antibody(DMC463); IgG1 Chimeric mAb
Price: 10μg $139.00 ; 100 μg $670.00 ; 500 μg $1999.00
Product Data
Images
Related Products
Monoclonal antibodies
SKU: DMC100463 Target: CD142
Application: Flow Cyt
Price: 10μg $99.00 ; 100 μg $446.00 ; 500 μg $1340.00
Monoclonal antibodies
PE-conjugated Anti-CD142 antibody(DMC463); IgG1 Chimeric mAb
SKU: DMC100463P Target: CD142
Application: Flow Cyt
Price: 100 test $550.00
Biosimilar reference antibodies
SKU: BME100661B Target: CD142
Application: N/A
Price: 50μg $99.00 ; 100 μg $199.00
Biosimilar reference antibodies
SKU: BME100124 Target: CD142
Application: ELISA, Flow Cyt
Price: 50μg $82.00 ; 100 μg $162.00
ECD Proteins
SKU: PME100751 Target: CD142
Price: 10μg $120.00 ; 50μg $450.00 ; 100 μg $660.00